GET THE APP

Acitretin versus Methotrexate in severe plaque psoriasis | 8768

Journal of Clinical & Experimental Dermatology Research

ISSN - 2155-9554

+44 1478 350008

Acitretin versus Methotrexate in severe plaque psoriasis

9th World Dermatology & Pediatric Dermatology Congress

October 10-11, 2016 Manchester, UK

Liu Panpan, Li Jie, Zhang Jianglin, Su Juan, Kuang Yehong, Chen Xiang and Zhu Wu

Central South University, China

Scientific Tracks Abstracts: J Clin Exp Dermatol Res

Abstract :

Objective: To compare acitretin and methotrexate in severe plaque psoriasis in terms of effectiveness and side effects. Methods: A total of 54 patients were assigned to treatment for 8 weeks with either acitretin (32 patients; 30 mg per day) or methotrexate (22 patients; 15 mg per week). The effectiveness of two kinds of drugs was assessed by psoriasis area and severity index (PASI). Results: After 8 weeks of treatment, the mean (�±s) score for PASI decreased from 24.46�±5.53 at base line to 9.65�±6.71 (P<0.001) among 32 patients treated with acitretin, whereas the score decreased from 25.21�±5.86 to 7.00�±4.56 (P<0.001) among 22 patients treated with methotrexate. However, there were no significant differences in the response rates of PASI between two groups and also in PASI50, PASI75 and PASI90 response rate (P>0.05). Conclusions: Acitretin and methotrexate in severe plaque psoriasis were similarly effective and the incidence of adverse reactions was low.

Biography :

Liu Panpan is currently a Master’s degree student at the Department of Dermatology, Xiangya Hospital, Central South University, China.

Email: liupanpan91@hotmail.com

Top
https://www.olimpbase.org/1937/